Loading…
The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation
A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called &quo...
Saved in:
Published in: | International journal of molecular sciences 2023-03, Vol.24 (6), p.5747 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23 |
---|---|
cites | cdi_FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23 |
container_end_page | |
container_issue | 6 |
container_start_page | 5747 |
container_title | International journal of molecular sciences |
container_volume | 24 |
creator | Itabe, Hiroyuki Obama, Takashi |
description | A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called "oxLDL hypothesis", as a mechanism for atherosclerosis development, has been attracting attention for decades. However, the oxLDL has been considered a hypothetical particle since the oxLDL present in vivo has not been fully characterized. Several chemically modified LDLs have been proposed to mimic oxLDLs. Some of the subfractions of LDL, especially Lp(a) and electronegative LDL, have been characterized as oxLDL candidates as oxidized phospholipids that stimulate vascular cells. Oxidized high-density lipoprotein (oxHDL) and oxLDL were discovered immunologically in vivo. Recently, an oxLDL-oxHDL complex was found in human plasma, suggesting the involvement of HDLs in the oxidative modification of lipoproteins in vivo. In this review, we summarize our understanding of oxidized lipoproteins and propose a novel standpoint to understand the oxidized lipoproteins present in vivo. |
doi_str_mv | 10.3390/ijms24065747 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10053446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A751926824</galeid><sourcerecordid>A751926824</sourcerecordid><originalsourceid>FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23</originalsourceid><addsrcrecordid>eNptkk1vEzEQQC1ERUvhxhlZ4sKBFH97zaUqAdpIkXopvVreXW8z0a4d7N2I8utx1NKmqPLBlufNs2Y8CL2j5IRzQz7DeshMECW10C_QERWMzQhR-uXe-RC9znlNCONMmlfokCtTsYrKI3R9tfL48je08Me3eAmbuElx9BAyXgR8Ddv4BS_GjL_B1qcM4y12ocVf_cptISYMAY9FcDENLuA5pGbq3QgxvEEHneuzf3u_H6OfP75fzS9my8vzxfxsOWukUONMcOFqRomsmOtIp7XgnstaVaoWutaGGE1JyygXWojKOdYw4zlTrm6IZp7xY3R6591M9eDbxocxud5uEgwu3drowD6NBFjZm7i1lBDJhVDF8PHekOKvyefRDpAb3_cu-Dhly7RhknCieUE__Ieu45RCqW9HUSVVRc0jdeN6byF0sTzc7KT2TEtqmKqYKNTJM1RZrR-gicF3UO6fJHy6S2hSzDn57qFISuxuEOz-IBT8_X5jHuB_P8__ApGVq9M</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2791656819</pqid></control><display><type>article</type><title>The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Itabe, Hiroyuki ; Obama, Takashi</creator><creatorcontrib>Itabe, Hiroyuki ; Obama, Takashi</creatorcontrib><description>A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called "oxLDL hypothesis", as a mechanism for atherosclerosis development, has been attracting attention for decades. However, the oxLDL has been considered a hypothetical particle since the oxLDL present in vivo has not been fully characterized. Several chemically modified LDLs have been proposed to mimic oxLDLs. Some of the subfractions of LDL, especially Lp(a) and electronegative LDL, have been characterized as oxLDL candidates as oxidized phospholipids that stimulate vascular cells. Oxidized high-density lipoprotein (oxHDL) and oxLDL were discovered immunologically in vivo. Recently, an oxLDL-oxHDL complex was found in human plasma, suggesting the involvement of HDLs in the oxidative modification of lipoproteins in vivo. In this review, we summarize our understanding of oxidized lipoproteins and propose a novel standpoint to understand the oxidized lipoproteins present in vivo.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms24065747</identifier><identifier>PMID: 36982815</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Arteriosclerosis ; Atherosclerosis ; Atherosclerosis - etiology ; Blood lipids ; Blood plasma ; Cardiovascular diseases ; Cardiovascular Diseases - complications ; Cholesterol ; Development and progression ; Electronegativity ; Enzymes ; High density lipoprotein ; Human acts ; Human behavior ; Humans ; Hypothetical particles ; Ligands ; Lipids ; Lipoprotein A ; Lipoproteins ; Lipoproteins, HDL ; Lipoproteins, LDL ; Low density lipoprotein ; Low density lipoprotein receptors ; Low density lipoproteins ; Medical research ; Membrane lipids ; Monoclonal antibodies ; Oxidation ; Phospholipids ; Plasma ; Proteins ; Review ; Risk Factors</subject><ispartof>International journal of molecular sciences, 2023-03, Vol.24 (6), p.5747</ispartof><rights>COPYRIGHT 2023 MDPI AG</rights><rights>2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2023 by the authors. 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23</citedby><cites>FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23</cites><orcidid>0000-0002-8044-9494</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2791656819/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2791656819?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36982815$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Itabe, Hiroyuki</creatorcontrib><creatorcontrib>Obama, Takashi</creatorcontrib><title>The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called "oxLDL hypothesis", as a mechanism for atherosclerosis development, has been attracting attention for decades. However, the oxLDL has been considered a hypothetical particle since the oxLDL present in vivo has not been fully characterized. Several chemically modified LDLs have been proposed to mimic oxLDLs. Some of the subfractions of LDL, especially Lp(a) and electronegative LDL, have been characterized as oxLDL candidates as oxidized phospholipids that stimulate vascular cells. Oxidized high-density lipoprotein (oxHDL) and oxLDL were discovered immunologically in vivo. Recently, an oxLDL-oxHDL complex was found in human plasma, suggesting the involvement of HDLs in the oxidative modification of lipoproteins in vivo. In this review, we summarize our understanding of oxidized lipoproteins and propose a novel standpoint to understand the oxidized lipoproteins present in vivo.</description><subject>Arteriosclerosis</subject><subject>Atherosclerosis</subject><subject>Atherosclerosis - etiology</subject><subject>Blood lipids</subject><subject>Blood plasma</subject><subject>Cardiovascular diseases</subject><subject>Cardiovascular Diseases - complications</subject><subject>Cholesterol</subject><subject>Development and progression</subject><subject>Electronegativity</subject><subject>Enzymes</subject><subject>High density lipoprotein</subject><subject>Human acts</subject><subject>Human behavior</subject><subject>Humans</subject><subject>Hypothetical particles</subject><subject>Ligands</subject><subject>Lipids</subject><subject>Lipoprotein A</subject><subject>Lipoproteins</subject><subject>Lipoproteins, HDL</subject><subject>Lipoproteins, LDL</subject><subject>Low density lipoprotein</subject><subject>Low density lipoprotein receptors</subject><subject>Low density lipoproteins</subject><subject>Medical research</subject><subject>Membrane lipids</subject><subject>Monoclonal antibodies</subject><subject>Oxidation</subject><subject>Phospholipids</subject><subject>Plasma</subject><subject>Proteins</subject><subject>Review</subject><subject>Risk Factors</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNptkk1vEzEQQC1ERUvhxhlZ4sKBFH97zaUqAdpIkXopvVreXW8z0a4d7N2I8utx1NKmqPLBlufNs2Y8CL2j5IRzQz7DeshMECW10C_QERWMzQhR-uXe-RC9znlNCONMmlfokCtTsYrKI3R9tfL48je08Me3eAmbuElx9BAyXgR8Ddv4BS_GjL_B1qcM4y12ocVf_cptISYMAY9FcDENLuA5pGbq3QgxvEEHneuzf3u_H6OfP75fzS9my8vzxfxsOWukUONMcOFqRomsmOtIp7XgnstaVaoWutaGGE1JyygXWojKOdYw4zlTrm6IZp7xY3R6591M9eDbxocxud5uEgwu3drowD6NBFjZm7i1lBDJhVDF8PHekOKvyefRDpAb3_cu-Dhly7RhknCieUE__Ieu45RCqW9HUSVVRc0jdeN6byF0sTzc7KT2TEtqmKqYKNTJM1RZrR-gicF3UO6fJHy6S2hSzDn57qFISuxuEOz-IBT8_X5jHuB_P8__ApGVq9M</recordid><startdate>20230317</startdate><enddate>20230317</enddate><creator>Itabe, Hiroyuki</creator><creator>Obama, Takashi</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8044-9494</orcidid></search><sort><creationdate>20230317</creationdate><title>The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation</title><author>Itabe, Hiroyuki ; Obama, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Arteriosclerosis</topic><topic>Atherosclerosis</topic><topic>Atherosclerosis - etiology</topic><topic>Blood lipids</topic><topic>Blood plasma</topic><topic>Cardiovascular diseases</topic><topic>Cardiovascular Diseases - complications</topic><topic>Cholesterol</topic><topic>Development and progression</topic><topic>Electronegativity</topic><topic>Enzymes</topic><topic>High density lipoprotein</topic><topic>Human acts</topic><topic>Human behavior</topic><topic>Humans</topic><topic>Hypothetical particles</topic><topic>Ligands</topic><topic>Lipids</topic><topic>Lipoprotein A</topic><topic>Lipoproteins</topic><topic>Lipoproteins, HDL</topic><topic>Lipoproteins, LDL</topic><topic>Low density lipoprotein</topic><topic>Low density lipoprotein receptors</topic><topic>Low density lipoproteins</topic><topic>Medical research</topic><topic>Membrane lipids</topic><topic>Monoclonal antibodies</topic><topic>Oxidation</topic><topic>Phospholipids</topic><topic>Plasma</topic><topic>Proteins</topic><topic>Review</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Itabe, Hiroyuki</creatorcontrib><creatorcontrib>Obama, Takashi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Itabe, Hiroyuki</au><au>Obama, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2023-03-17</date><risdate>2023</risdate><volume>24</volume><issue>6</issue><spage>5747</spage><pages>5747-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>A high concentration of low-density lipoproteins (LDLs) in circulation has been well-known as a major risk factor for cardiovascular diseases. The presence of oxidized LDLs (oxLDLs) in atherosclerotic lesions and circulation was demonstrated using anti-oxLDL monoclonal antibodies. The so-called "oxLDL hypothesis", as a mechanism for atherosclerosis development, has been attracting attention for decades. However, the oxLDL has been considered a hypothetical particle since the oxLDL present in vivo has not been fully characterized. Several chemically modified LDLs have been proposed to mimic oxLDLs. Some of the subfractions of LDL, especially Lp(a) and electronegative LDL, have been characterized as oxLDL candidates as oxidized phospholipids that stimulate vascular cells. Oxidized high-density lipoprotein (oxHDL) and oxLDL were discovered immunologically in vivo. Recently, an oxLDL-oxHDL complex was found in human plasma, suggesting the involvement of HDLs in the oxidative modification of lipoproteins in vivo. In this review, we summarize our understanding of oxidized lipoproteins and propose a novel standpoint to understand the oxidized lipoproteins present in vivo.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>36982815</pmid><doi>10.3390/ijms24065747</doi><orcidid>https://orcid.org/0000-0002-8044-9494</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1422-0067 |
ispartof | International journal of molecular sciences, 2023-03, Vol.24 (6), p.5747 |
issn | 1422-0067 1661-6596 1422-0067 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10053446 |
source | Publicly Available Content Database; PubMed Central |
subjects | Arteriosclerosis Atherosclerosis Atherosclerosis - etiology Blood lipids Blood plasma Cardiovascular diseases Cardiovascular Diseases - complications Cholesterol Development and progression Electronegativity Enzymes High density lipoprotein Human acts Human behavior Humans Hypothetical particles Ligands Lipids Lipoprotein A Lipoproteins Lipoproteins, HDL Lipoproteins, LDL Low density lipoprotein Low density lipoprotein receptors Low density lipoproteins Medical research Membrane lipids Monoclonal antibodies Oxidation Phospholipids Plasma Proteins Review Risk Factors |
title | The Oxidized Lipoproteins In Vivo: Its Diversity and Behavior in the Human Circulation |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T23%3A54%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Oxidized%20Lipoproteins%20In%20Vivo:%20Its%20Diversity%20and%20Behavior%20in%20the%20Human%20Circulation&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Itabe,%20Hiroyuki&rft.date=2023-03-17&rft.volume=24&rft.issue=6&rft.spage=5747&rft.pages=5747-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms24065747&rft_dat=%3Cgale_pubme%3EA751926824%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c546t-434ab210582af0f7743e35b686b47b7909710d21347448aa2c29e326abc072e23%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2791656819&rft_id=info:pmid/36982815&rft_galeid=A751926824&rfr_iscdi=true |